1. Home
  2. XFOR vs UPLD Comparison

XFOR vs UPLD Comparison

Compare XFOR & UPLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XFOR
  • UPLD
  • Stock Information
  • Founded
  • XFOR 2014
  • UPLD 2010
  • Country
  • XFOR United States
  • UPLD United States
  • Employees
  • XFOR N/A
  • UPLD N/A
  • Industry
  • XFOR Biotechnology: Biological Products (No Diagnostic Substances)
  • UPLD Computer Software: Prepackaged Software
  • Sector
  • XFOR Health Care
  • UPLD Technology
  • Exchange
  • XFOR Nasdaq
  • UPLD Nasdaq
  • Market Cap
  • XFOR 118.4M
  • UPLD 115.3M
  • IPO Year
  • XFOR N/A
  • UPLD 2014
  • Fundamental
  • Price
  • XFOR $0.47
  • UPLD $4.09
  • Analyst Decision
  • XFOR Strong Buy
  • UPLD Hold
  • Analyst Count
  • XFOR 3
  • UPLD 3
  • Target Price
  • XFOR $3.50
  • UPLD $3.75
  • AVG Volume (30 Days)
  • XFOR 6.8M
  • UPLD 175.2K
  • Earning Date
  • XFOR 03-20-2025
  • UPLD 03-04-2025
  • Dividend Yield
  • XFOR N/A
  • UPLD N/A
  • EPS Growth
  • XFOR N/A
  • UPLD N/A
  • EPS
  • XFOR N/A
  • UPLD N/A
  • Revenue
  • XFOR $1,123,000.00
  • UPLD $278,945,000.00
  • Revenue This Year
  • XFOR N/A
  • UPLD N/A
  • Revenue Next Year
  • XFOR $590.67
  • UPLD N/A
  • P/E Ratio
  • XFOR N/A
  • UPLD N/A
  • Revenue Growth
  • XFOR N/A
  • UPLD N/A
  • 52 Week Low
  • XFOR $0.26
  • UPLD $1.79
  • 52 Week High
  • XFOR $1.60
  • UPLD $5.64
  • Technical
  • Relative Strength Index (RSI)
  • XFOR 41.75
  • UPLD 46.14
  • Support Level
  • XFOR $0.46
  • UPLD $4.14
  • Resistance Level
  • XFOR $0.54
  • UPLD $4.79
  • Average True Range (ATR)
  • XFOR 0.05
  • UPLD 0.27
  • MACD
  • XFOR -0.01
  • UPLD 0.02
  • Stochastic Oscillator
  • XFOR 5.63
  • UPLD 33.33

About XFOR X4 Pharmaceuticals Inc.

X4 Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company engaged in the research and development of novel therapeutics for the treatment of rare diseases and those with limited treatment options, with a focus on conditions resulting from dysfunction of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It has the ability to increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.

About UPLD Upland Software Inc.

Upland Software Inc is a provider of cloud-based enterprise work management software. The company provides a family of cloud-based enterprise work management software applications for the information technology, process excellence, finance, professional services and marketing functions within organizations. It services customers ranging from corporations and Government agencies to small- and medium-sized businesses engaged in the field of financial services, retail, technology, manufacturing, education, consumer goods, media, and telecommunications, Government, food and beverage, healthcare and life sciences, chemicals and travel and hospitality. The products of the company are Altify, BA Insight, InGenius, Panviva, Qvidian, RightAnswers and others.

Share on Social Networks: